Portfolio Details

NeoChord, Inc.

NeoChord Logo
Current
NeoChord is a medical technology company focused on advancing the treatment of mitral regurgitation.
Learn more about the company
NeoChord Logo
Current
Team
Venture Capital
Invested Date
June 2015
Status
Active
Location
U.S.

Share

See All Transactions

Related Content

Operating room lights
NeoChord Announces Successful In-Human Procedure

Baird Capital portfolio company NeoChord recently announced successful completion of the first-in-human procedure with the NeoChord NeXuS Transcatheter Mitral Chordal Repair technology (TMVr).